DB
AGL icon

Dmitry Balyasny’s Agilon Health AGL Stock Holding History

Dmitry Balyasny’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.79M Buy
+26,022
New +$1.7M ﹤0.01% 1656
2026
Q1 		– Sell
-6,231
Closed -$107K – 2829
2025
Q4 		$107K Sell
6,231
-5,507
-47% -$107K ﹤0.01% 2950
2025
Q3 		$302K Buy
11,738
+8,254
+237% +$312K ﹤0.01% 2574
2025
Q2 		$200K Buy
3,484
+1,917
+122% +$154K ﹤0.01% 2594
2025
Q1 		$170K Buy
+1,567
New +$136K ﹤0.01% 2619
2024
Q4 		– Sell
-6,757
Closed -$664K – 2683
2024
Q3 		$664K Buy
+6,757
New +$872K ﹤0.01% 2142
2024
Q2 		– Sell
-23,685
Closed -$3.61M – 2522
2024
Q1 		$3.61M Buy
+23,685
New +$3.94M 0.01% 1344
2021
Q3 		– Sell
-580
Closed -$588K – 1892
2021
Q2 		$588K Buy
+580
New +$508K ﹤0.01% 1495

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Dmitry Balyasny's AGL Position: Q2 2026 in Review

Dmitry Balyasny opened a new position in Agilon Health (AGL) in Q2 2026: 26,022 shares worth $2.79M. The stake represents ﹤0.01% of the portfolio and ranks #1656 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in AGL as recently as Q4 2025.

Dmitry Balyasny first reported a position in AGL in Q2 2021 and has held it in 8 quarters since. The position peaked at $3.61M in Q1 2024. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Dmitry Balyasny held 26,022 shares of Agilon Health worth $2.79M as of Q2 2026.
  • Agilon Health was a new Dmitry Balyasny position in Q2 2026.
  • Agilon Health made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #1656 holding.
  • Dmitry Balyasny first reported a position in Agilon Health in Q2 2021 and has held it in 8 quarters since.
  • Dmitry Balyasny's Agilon Health position peaked at $3.61M in Q1 2024.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.